StockWatch
·

ASTRAZENECA PHARMA INDIA LTD.

BSE: 506820

values in crores

Revenue & Profit Trend

in crores
RevenueExpenditureNet Profit
-56.26195.39447.03698.68Q2 FY2025Q3 FY2025Q4 FY2025Q1 FY2026Q2 FY2026Q3 FY2026Q4 FY2026

Margin Trend

percentage
OPM %NPM %
3.558.5413.5318.52Q2 FY2025Q3 FY2025Q4 FY2025Q1 FY2026Q2 FY2026Q3 FY2026Q4 FY2026
PeriodQ4 FY2026Q3 FY2026Q2 FY2026Q1 FY2026Q4 FY2025Q3 FY2025Q2 FY2025
INCOME
Revenue578.61-5.4%611.57+9.4%559.09+6.2%526.31+9.5%480.48+9.1%440.29+7.9%408.00
Other Income5.95+16.0%5.13-16.9%6.17-45.1%11.24-30.4%16.15+102.3%7.98-2.1%8.15
Total Income584.56-5.2%616.70+9.1%565.26+5.2%537.55+8.2%496.63+10.8%448.27+7.7%416.15
EXPENSES
Expenditure525.34-8.1%571.64+17.3%487.15+5.3%462.49+12.1%412.48+10.7%372.70+2.1%365.12
Tax13.26-4.9%13.95-25.0%18.60-1.4%18.87-6.7%20.22+81.1%11.17-11.4%12.60
PROFIT
PBT58.14+24.9%46.54-36.1%72.82-2.5%74.70-4.8%78.47+86.7%42.02-17.7%51.03
Net Profit44.88+37.7%32.59-39.9%54.22-2.9%55.83-4.2%58.25+88.8%30.85-19.7%38.43
KEY METRICS
OPM %10.34%+2.77pp7.57%-4.93pp12.50%-2.84pp15.34%-1.45pp16.79%+11.19pp5.60%-2.54pp8.14%
NPM %7.68%+2.40pp5.28%-4.31pp9.59%-0.80pp10.39%-1.34pp11.73%+4.85pp6.88%-2.35pp9.23%
EPS17.95+37.7%13.04-39.9%21.69-2.9%22.33-4.2%23.30+88.8%12.34-19.7%15.37

Corporate Events

Board MeetingASTRAZEN
2026
26May

Board Meeting

To consider and approve the audited financial results for th…

BSE Filing
DividendASTRAZEN
2025
30May

₹32 / share

BSE Filing
Board MeetingASTRAZEN
2024
13Nov

Board Meeting

Consider and approve the Unaudited Financial Results

BSE Filing
Board MeetingASTRAZEN
2024
8Aug

Board Meeting

Consider and approve the Unaudited Financial Results

BSE Filing
Board MeetingASTRAZEN
2024
27May

Board Meeting

To consider and approve the Audited financial results of the…

BSE Filing
Board MeetingASTRAZEN
2024
8Feb

Board Meeting

Consider and approve Unaudited Financial Results for the qua…

BSE Filing
Board MeetingASTRAZEN
2023
9Nov

Board Meeting

Consider and approve Unaudited Financial Results for the qua…

BSE Filing
Board MeetingASTRAZEN
2023
14Aug

Board Meeting

Consider and approve the Unaudited Financial Results for the…

BSE Filing